The global market for Venous Thromboembolism Treatment Options was estimated to be worth US$ 356.5 million in 2023 and is forecast to a readjusted size of US$ 463.6 million by 2030 with a CAGR of 3.5% during the forecast period 2024-2030

Venous Thromboembolism Treatment Options - Market

The most common treatment for deep vein thrombosis is the use of anticoagulants, also known as blood thinners. These medicines, which can be taken by injection or pill, can reduce your blood's ability to clot. They don't break down existing clots, but they prevent them from getting bigger and reduce the risk of more clots forming. Injectable drugs can be given either subcutaneously or intravenously.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Venous Thromboembolism Treatment Options, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Venous Thromboembolism Treatment Options by region & country, by Type, and by Application.

The Venous Thromboembolism Treatment Options market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Venous Thromboembolism Treatment Options.

Market Segmentation

Scope of Venous Thromboembolism Treatment Options - Market Report

Report Metric	Details
Report Name	Venous Thromboembolism Treatment Options - Market
Forecasted market size in 2030	US$ 463.6 million
CAGR	3.5%
Forecasted years	2024 - 2030
Segment by Type:	Upper Pneumatic Compression Sleeves Lower Pneumatic Compression Sleeves Permanent Inferior Vena Cava Filters Others
Segment by Application	Hospitals Catheterisation Laboratories Ambulatory Surgical Centers
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AngioDynamics, Cardinal Health Inc., BTG International Ltd., Stryker Corporation, DJO Global Inc., EKOS Corp, Teleflex Inc., Boston Scientific Corp., Janssen Pharmaceuticals, Inc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Venous Thromboembolism Treatment Options manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Venous Thromboembolism Treatment Options in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Venous Thromboembolism Treatment Options in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Venous Thromboembolism Treatment Options - Market size in 2030?

Ans: The Venous Thromboembolism Treatment Options - Market size in 2030 will be US$ 463.6 million.

Who are the main players in the Venous Thromboembolism Treatment Options - Market report?

Ans: The main players in the Venous Thromboembolism Treatment Options - Market are AngioDynamics, Cardinal Health Inc., BTG International Ltd., Stryker Corporation, DJO Global Inc., EKOS Corp, Teleflex Inc., Boston Scientific Corp., Janssen Pharmaceuticals, Inc

What are the Application segmentation covered in the Venous Thromboembolism Treatment Options - Market report?

Ans: The Applications covered in the Venous Thromboembolism Treatment Options - Market report are Hospitals, Catheterisation Laboratories, Ambulatory Surgical Centers

What are the Type segmentation covered in the Venous Thromboembolism Treatment Options - Market report?

Ans: The Types covered in the Venous Thromboembolism Treatment Options - Market report are Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters, Others

1 Market Overview

1.1 Venous Thromboembolism Treatment Options Product Introduction

1.2 Global Venous Thromboembolism Treatment Options Market Size Forecast

1.2.1 Global Venous Thromboembolism Treatment Options Sales Value (2019-2030)

1.2.2 Global Venous Thromboembolism Treatment Options Sales Volume (2019-2030)

1.2.3 Global Venous Thromboembolism Treatment Options Sales Price (2019-2030)

1.3 Venous Thromboembolism Treatment Options Market Trends & Drivers

1.3.1 Venous Thromboembolism Treatment Options Industry Trends

1.3.2 Venous Thromboembolism Treatment Options Market Drivers & Opportunity

1.3.3 Venous Thromboembolism Treatment Options Market Challenges

1.3.4 Venous Thromboembolism Treatment Options Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Venous Thromboembolism Treatment Options Players Revenue Ranking (2023)

2.2 Global Venous Thromboembolism Treatment Options Revenue by Company (2019-2024)

2.3 Global Venous Thromboembolism Treatment Options Players Sales Volume Ranking (2023)

2.4 Global Venous Thromboembolism Treatment Options Sales Volume by Company Players (2019-2024)

2.5 Global Venous Thromboembolism Treatment Options Average Price by Company (2019-2024)

2.6 Key Manufacturers Venous Thromboembolism Treatment Options Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Venous Thromboembolism Treatment Options Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Venous Thromboembolism Treatment Options

2.9 Venous Thromboembolism Treatment Options Market Competitive Analysis

2.9.1 Venous Thromboembolism Treatment Options Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Venous Thromboembolism Treatment Options Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Venous Thromboembolism Treatment Options as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Upper Pneumatic Compression Sleeves

3.1.2 Lower Pneumatic Compression Sleeves

3.1.3 Permanent Inferior Vena Cava Filters

3.1.4 Others

3.2 Global Venous Thromboembolism Treatment Options Sales Value by Type

3.2.1 Global Venous Thromboembolism Treatment Options Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Venous Thromboembolism Treatment Options Sales Value, by Type (2019-2030)

3.2.3 Global Venous Thromboembolism Treatment Options Sales Value, by Type (%) (2019-2030)

3.3 Global Venous Thromboembolism Treatment Options Sales Volume by Type

3.3.1 Global Venous Thromboembolism Treatment Options Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Venous Thromboembolism Treatment Options Sales Volume, by Type (2019-2030)

3.3.3 Global Venous Thromboembolism Treatment Options Sales Volume, by Type (%) (2019-2030)

3.4 Global Venous Thromboembolism Treatment Options Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 Catheterisation Laboratories

4.1.3 Ambulatory Surgical Centers

4.2 Global Venous Thromboembolism Treatment Options Sales Value by Application

4.2.1 Global Venous Thromboembolism Treatment Options Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Venous Thromboembolism Treatment Options Sales Value, by Application (2019-2030)

4.2.3 Global Venous Thromboembolism Treatment Options Sales Value, by Application (%) (2019-2030)

4.3 Global Venous Thromboembolism Treatment Options Sales Volume by Application

4.3.1 Global Venous Thromboembolism Treatment Options Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Venous Thromboembolism Treatment Options Sales Volume, by Application (2019-2030)

4.3.3 Global Venous Thromboembolism Treatment Options Sales Volume, by Application (%) (2019-2030)

4.4 Global Venous Thromboembolism Treatment Options Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Venous Thromboembolism Treatment Options Sales Value by Region

5.1.1 Global Venous Thromboembolism Treatment Options Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Venous Thromboembolism Treatment Options Sales Value by Region (2019-2024)

5.1.3 Global Venous Thromboembolism Treatment Options Sales Value by Region (2025-2030)

5.1.4 Global Venous Thromboembolism Treatment Options Sales Value by Region (%), (2019-2030)

5.2 Global Venous Thromboembolism Treatment Options Sales Volume by Region

5.2.1 Global Venous Thromboembolism Treatment Options Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Venous Thromboembolism Treatment Options Sales Volume by Region (2019-2024)

5.2.3 Global Venous Thromboembolism Treatment Options Sales Volume by Region (2025-2030)

5.2.4 Global Venous Thromboembolism Treatment Options Sales Volume by Region (%), (2019-2030)

5.3 Global Venous Thromboembolism Treatment Options Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Venous Thromboembolism Treatment Options Sales Value, 2019-2030

5.4.2 North America Venous Thromboembolism Treatment Options Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Venous Thromboembolism Treatment Options Sales Value, 2019-2030

5.5.2 Europe Venous Thromboembolism Treatment Options Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Venous Thromboembolism Treatment Options Sales Value, 2019-2030

5.6.2 Asia Pacific Venous Thromboembolism Treatment Options Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Venous Thromboembolism Treatment Options Sales Value, 2019-2030

5.7.2 South America Venous Thromboembolism Treatment Options Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Venous Thromboembolism Treatment Options Sales Value, 2019-2030

5.8.2 Middle East & Africa Venous Thromboembolism Treatment Options Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Venous Thromboembolism Treatment Options Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Venous Thromboembolism Treatment Options Sales Value

6.2.1 Key Countries/Regions Venous Thromboembolism Treatment Options Sales Value, 2019-2030

6.2.2 Key Countries/Regions Venous Thromboembolism Treatment Options Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Venous Thromboembolism Treatment Options Sales Value, 2019-2030

6.3.2 United States Venous Thromboembolism Treatment Options Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Venous Thromboembolism Treatment Options Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Venous Thromboembolism Treatment Options Sales Value, 2019-2030

6.4.2 Europe Venous Thromboembolism Treatment Options Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Venous Thromboembolism Treatment Options Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Venous Thromboembolism Treatment Options Sales Value, 2019-2030

6.5.2 China Venous Thromboembolism Treatment Options Sales Value by Type (%), 2023 VS 2030

6.5.3 China Venous Thromboembolism Treatment Options Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Venous Thromboembolism Treatment Options Sales Value, 2019-2030

6.6.2 Japan Venous Thromboembolism Treatment Options Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Venous Thromboembolism Treatment Options Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Venous Thromboembolism Treatment Options Sales Value, 2019-2030

6.7.2 South Korea Venous Thromboembolism Treatment Options Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Venous Thromboembolism Treatment Options Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Venous Thromboembolism Treatment Options Sales Value, 2019-2030

6.8.2 Southeast Asia Venous Thromboembolism Treatment Options Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Venous Thromboembolism Treatment Options Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Venous Thromboembolism Treatment Options Sales Value, 2019-2030

6.9.2 India Venous Thromboembolism Treatment Options Sales Value by Type (%), 2023 VS 2030

6.9.3 India Venous Thromboembolism Treatment Options Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 AngioDynamics

7.1.1 AngioDynamics Company Information

7.1.2 AngioDynamics Introduction and Business Overview

7.1.3 AngioDynamics Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2019-2024)

7.1.4 AngioDynamics Venous Thromboembolism Treatment Options Product Offerings

7.1.5 AngioDynamics Recent Development

7.2 Cardinal Health Inc.

7.2.1 Cardinal Health Inc. Company Information

7.2.2 Cardinal Health Inc. Introduction and Business Overview

7.2.3 Cardinal Health Inc. Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Cardinal Health Inc. Venous Thromboembolism Treatment Options Product Offerings

7.2.5 Cardinal Health Inc. Recent Development

7.3 BTG International Ltd.

7.3.1 BTG International Ltd. Company Information

7.3.2 BTG International Ltd. Introduction and Business Overview

7.3.3 BTG International Ltd. Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2019-2024)

7.3.4 BTG International Ltd. Venous Thromboembolism Treatment Options Product Offerings

7.3.5 BTG International Ltd. Recent Development

7.4 Stryker Corporation

7.4.1 Stryker Corporation Company Information

7.4.2 Stryker Corporation Introduction and Business Overview

7.4.3 Stryker Corporation Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Stryker Corporation Venous Thromboembolism Treatment Options Product Offerings

7.4.5 Stryker Corporation Recent Development

7.5 DJO Global Inc.

7.5.1 DJO Global Inc. Company Information

7.5.2 DJO Global Inc. Introduction and Business Overview

7.5.3 DJO Global Inc. Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2019-2024)

7.5.4 DJO Global Inc. Venous Thromboembolism Treatment Options Product Offerings

7.5.5 DJO Global Inc. Recent Development

7.6 EKOS Corp

7.6.1 EKOS Corp Company Information

7.6.2 EKOS Corp Introduction and Business Overview

7.6.3 EKOS Corp Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2019-2024)

7.6.4 EKOS Corp Venous Thromboembolism Treatment Options Product Offerings

7.6.5 EKOS Corp Recent Development

7.7 Teleflex Inc., Boston Scientific Corp.

7.7.1 Teleflex Inc., Boston Scientific Corp. Company Information

7.7.2 Teleflex Inc., Boston Scientific Corp. Introduction and Business Overview

7.7.3 Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Product Offerings

7.7.5 Teleflex Inc., Boston Scientific Corp. Recent Development

7.8 Janssen Pharmaceuticals, Inc

7.8.1 Janssen Pharmaceuticals, Inc Company Information

7.8.2 Janssen Pharmaceuticals, Inc Introduction and Business Overview

7.8.3 Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Product Offerings

7.8.5 Janssen Pharmaceuticals, Inc Recent Development

8 Industry Chain Analysis

8.1 Venous Thromboembolism Treatment Options Industrial Chain

8.2 Venous Thromboembolism Treatment Options Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Venous Thromboembolism Treatment Options Sales Model

8.5.2 Sales Channel

8.5.3 Venous Thromboembolism Treatment Options Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

AngioDynamics

Cardinal Health Inc.

BTG International Ltd

Stryker Corporation

DJO Global Inc.

Janssen Pharmaceuticals, Inc.

EKOS Corp

Teleflex Inc., Boston Scientific Corp.

List of Tables

Table 1. Venous Thromboembolism Treatment Options Market Trends

Table 2. Venous Thromboembolism Treatment Options Market Drivers & Opportunity

Table 3. Venous Thromboembolism Treatment Options Market Challenges

Table 4. Venous Thromboembolism Treatment Options Market Restraints

Table 5. Global Venous Thromboembolism Treatment Options Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Venous Thromboembolism Treatment Options Revenue Market Share by Company (2019-2024)

Table 7. Global Venous Thromboembolism Treatment Options Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Venous Thromboembolism Treatment Options Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Venous Thromboembolism Treatment Options Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Venous Thromboembolism Treatment Options Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Venous Thromboembolism Treatment Options Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Venous Thromboembolism Treatment Options

Table 13. Global Venous Thromboembolism Treatment Options Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Venous Thromboembolism Treatment Options as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Venous Thromboembolism Treatment Options Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Venous Thromboembolism Treatment Options Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Venous Thromboembolism Treatment Options Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Venous Thromboembolism Treatment Options Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Venous Thromboembolism Treatment Options Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Venous Thromboembolism Treatment Options Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Venous Thromboembolism Treatment Options Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Venous Thromboembolism Treatment Options Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Venous Thromboembolism Treatment Options Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Venous Thromboembolism Treatment Options Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Venous Thromboembolism Treatment Options Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Venous Thromboembolism Treatment Options Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Venous Thromboembolism Treatment Options Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Venous Thromboembolism Treatment Options Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Venous Thromboembolism Treatment Options Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Venous Thromboembolism Treatment Options Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Venous Thromboembolism Treatment Options Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Venous Thromboembolism Treatment Options Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Venous Thromboembolism Treatment Options Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Venous Thromboembolism Treatment Options Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Venous Thromboembolism Treatment Options Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Venous Thromboembolism Treatment Options Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Venous Thromboembolism Treatment Options Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Venous Thromboembolism Treatment Options Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Venous Thromboembolism Treatment Options Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Venous Thromboembolism Treatment Options Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Venous Thromboembolism Treatment Options Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Venous Thromboembolism Treatment Options Sales Value by Region (2019-2024) & (%)

Table 44. Global Venous Thromboembolism Treatment Options Sales Value by Region (2025-2030) & (%)

Table 45. Global Venous Thromboembolism Treatment Options Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Venous Thromboembolism Treatment Options Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Venous Thromboembolism Treatment Options Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Venous Thromboembolism Treatment Options Sales Volume by Region (2019-2024) & (%)

Table 49. Global Venous Thromboembolism Treatment Options Sales Volume by Region (2025-2030) & (%)

Table 50. Global Venous Thromboembolism Treatment Options Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Venous Thromboembolism Treatment Options Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Venous Thromboembolism Treatment Options Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Venous Thromboembolism Treatment Options Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Venous Thromboembolism Treatment Options Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Venous Thromboembolism Treatment Options Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Venous Thromboembolism Treatment Options Sales Volume, (2025-2030) & (K Units)

Table 57. AngioDynamics Company Information

Table 58. AngioDynamics Introduction and Business Overview

Table 59. AngioDynamics Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. AngioDynamics Venous Thromboembolism Treatment Options Product Offerings

Table 61. AngioDynamics Recent Development

Table 62. Cardinal Health Inc. Company Information

Table 63. Cardinal Health Inc. Introduction and Business Overview

Table 64. Cardinal Health Inc. Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Cardinal Health Inc. Venous Thromboembolism Treatment Options Product Offerings

Table 66. Cardinal Health Inc. Recent Development

Table 67. BTG International Ltd. Company Information

Table 68. BTG International Ltd. Introduction and Business Overview

Table 69. BTG International Ltd. Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. BTG International Ltd. Venous Thromboembolism Treatment Options Product Offerings

Table 71. BTG International Ltd. Recent Development

Table 72. Stryker Corporation Company Information

Table 73. Stryker Corporation Introduction and Business Overview

Table 74. Stryker Corporation Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Stryker Corporation Venous Thromboembolism Treatment Options Product Offerings

Table 76. Stryker Corporation Recent Development

Table 77. DJO Global Inc. Company Information

Table 78. DJO Global Inc. Introduction and Business Overview

Table 79. DJO Global Inc. Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. DJO Global Inc. Venous Thromboembolism Treatment Options Product Offerings

Table 81. DJO Global Inc. Recent Development

Table 82. EKOS Corp Company Information

Table 83. EKOS Corp Introduction and Business Overview

Table 84. EKOS Corp Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. EKOS Corp Venous Thromboembolism Treatment Options Product Offerings

Table 86. EKOS Corp Recent Development

Table 87. Teleflex Inc., Boston Scientific Corp. Company Information

Table 88. Teleflex Inc., Boston Scientific Corp. Introduction and Business Overview

Table 89. Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Product Offerings

Table 91. Teleflex Inc., Boston Scientific Corp. Recent Development

Table 92. Janssen Pharmaceuticals, Inc Company Information

Table 93. Janssen Pharmaceuticals, Inc Introduction and Business Overview

Table 94. Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Product Offerings

Table 96. Janssen Pharmaceuticals, Inc Recent Development

Table 97. Key Raw Materials Lists

Table 98. Raw Materials Key Suppliers Lists

Table 99. Venous Thromboembolism Treatment Options Downstream Customers

Table 100. Venous Thromboembolism Treatment Options Distributors List

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Venous Thromboembolism Treatment Options Product Picture

Figure 2. Global Venous Thromboembolism Treatment Options Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Venous Thromboembolism Treatment Options Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Venous Thromboembolism Treatment Options Sales Volume (2019-2030) & (K Units)

Figure 5. Global Venous Thromboembolism Treatment Options Sales Price (2019-2030) & (US$/Unit)

Figure 6. Venous Thromboembolism Treatment Options Report Years Considered

Figure 7. Global Venous Thromboembolism Treatment Options Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Venous Thromboembolism Treatment Options Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Venous Thromboembolism Treatment Options Revenue in 2023

Figure 10. Venous Thromboembolism Treatment Options Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Upper Pneumatic Compression Sleeves Picture

Figure 12. Lower Pneumatic Compression Sleeves Picture

Figure 13. Permanent Inferior Vena Cava Filters Picture

Figure 14. Others Picture

Figure 15. Global Venous Thromboembolism Treatment Options Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Venous Thromboembolism Treatment Options Sales Value Market Share by Type, 2023 & 2030

Figure 17. Global Venous Thromboembolism Treatment Options Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 18. Global Venous Thromboembolism Treatment Options Sales Volume Market Share by Type, 2023 & 2030

Figure 19. Global Venous Thromboembolism Treatment Options Price by Type (2019-2030) & (US$/Unit)

Figure 20. Product Picture of Hospitals

Figure 21. Product Picture of Catheterisation Laboratories

Figure 22. Product Picture of Ambulatory Surgical Centers

Figure 23. Global Venous Thromboembolism Treatment Options Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 24. Global Venous Thromboembolism Treatment Options Sales Value Market Share by Application, 2023 & 2030

Figure 25. Global Venous Thromboembolism Treatment Options Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 26. Global Venous Thromboembolism Treatment Options Sales Volume Market Share by Application, 2023 & 2030

Figure 27. Global Venous Thromboembolism Treatment Options Price by Application (2019-2030) & (US$/Unit)

Figure 28. North America Venous Thromboembolism Treatment Options Sales Value (2019-2030) & (US$ Million)

Figure 29. North America Venous Thromboembolism Treatment Options Sales Value by Country (%), 2023 VS 2030

Figure 30. Europe Venous Thromboembolism Treatment Options Sales Value (2019-2030) & (US$ Million)

Figure 31. Europe Venous Thromboembolism Treatment Options Sales Value by Country (%), 2023 VS 2030

Figure 32. Asia Pacific Venous Thromboembolism Treatment Options Sales Value (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Venous Thromboembolism Treatment Options Sales Value by Country (%), 2023 VS 2030

Figure 34. South America Venous Thromboembolism Treatment Options Sales Value (2019-2030) & (US$ Million)

Figure 35. South America Venous Thromboembolism Treatment Options Sales Value by Country (%), 2023 VS 2030

Figure 36. Middle East & Africa Venous Thromboembolism Treatment Options Sales Value (2019-2030) & (US$ Million)

Figure 37. Middle East & Africa Venous Thromboembolism Treatment Options Sales Value by Country (%), 2023 VS 2030

Figure 38. Key Countries/Regions Venous Thromboembolism Treatment Options Sales Value (%), (2019-2030)

Figure 39. Key Countries/Regions Venous Thromboembolism Treatment Options Sales Volume (%), (2019-2030)

Figure 40. United States Venous Thromboembolism Treatment Options Sales Value, (2019-2030) & (US$ Million)

Figure 41. United States Venous Thromboembolism Treatment Options Sales Value by Type (%), 2023 VS 2030

Figure 42. United States Venous Thromboembolism Treatment Options Sales Value by Application (%), 2023 VS 2030

Figure 43. Europe Venous Thromboembolism Treatment Options Sales Value, (2019-2030) & (US$ Million)

Figure 44. Europe Venous Thromboembolism Treatment Options Sales Value by Type (%), 2023 VS 2030

Figure 45. Europe Venous Thromboembolism Treatment Options Sales Value by Application (%), 2023 VS 2030

Figure 46. China Venous Thromboembolism Treatment Options Sales Value, (2019-2030) & (US$ Million)

Figure 47. China Venous Thromboembolism Treatment Options Sales Value by Type (%), 2023 VS 2030

Figure 48. China Venous Thromboembolism Treatment Options Sales Value by Application (%), 2023 VS 2030

Figure 49. Japan Venous Thromboembolism Treatment Options Sales Value, (2019-2030) & (US$ Million)

Figure 50. Japan Venous Thromboembolism Treatment Options Sales Value by Type (%), 2023 VS 2030

Figure 51. Japan Venous Thromboembolism Treatment Options Sales Value by Application (%), 2023 VS 2030

Figure 52. South Korea Venous Thromboembolism Treatment Options Sales Value, (2019-2030) & (US$ Million)

Figure 53. South Korea Venous Thromboembolism Treatment Options Sales Value by Type (%), 2023 VS 2030

Figure 54. South Korea Venous Thromboembolism Treatment Options Sales Value by Application (%), 2023 VS 2030

Figure 55. Southeast Asia Venous Thromboembolism Treatment Options Sales Value, (2019-2030) & (US$ Million)

Figure 56. Southeast Asia Venous Thromboembolism Treatment Options Sales Value by Type (%), 2023 VS 2030

Figure 57. Southeast Asia Venous Thromboembolism Treatment Options Sales Value by Application (%), 2023 VS 2030

Figure 58. India Venous Thromboembolism Treatment Options Sales Value, (2019-2030) & (US$ Million)

Figure 59. India Venous Thromboembolism Treatment Options Sales Value by Type (%), 2023 VS 2030

Figure 60. India Venous Thromboembolism Treatment Options Sales Value by Application (%), 2023 VS 2030

Figure 61. Venous Thromboembolism Treatment Options Industrial Chain

Figure 62. Venous Thromboembolism Treatment Options Manufacturing Cost Structure

Figure 63. Channels of Distribution (Direct Sales, and Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-0M15054

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global Intravascular Stent Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-34N8228

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Cardiac Surgery Radiofrequency Ablation Apparatus - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-4H14831

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-28D18419

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Venous Thromboembolism Treatment Options - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: November 2024

Report Code: QYRE-Auto-38X10315

Venous Thromboembolism Treatment Options - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Venous Thromboembolism Treatment Options - Market Size

Venous Thromboembolism Treatment Options - Market

Report Scope

Scope of Venous Thromboembolism Treatment Options - Market Report

Chapter Outline

FAQ for this report

What is the Venous Thromboembolism Treatment Options - Market size in 2030?

Who are the main players in the Venous Thromboembolism Treatment Options - Market report?

What are the Application segmentation covered in the Venous Thromboembolism Treatment Options - Market report?

What are the Type segmentation covered in the Venous Thromboembolism Treatment Options - Market report?

FEATURED COMPANIES

RELATED REPORTS